Show simple item record

dc.contributor.authorOliveira Sato, J. de [UNESP]
dc.contributor.authorAlbuquerque Pedrosa Fernandes, T. de [UNESP]
dc.contributor.authorBicalho do Nascimento, C. [UNESP]
dc.contributor.authorCorrente, José Eduardo [UNESP]
dc.contributor.authorSaad-Magalhaes, C. [UNESP]
dc.identifier.citationClinical and Experimental Rheumatology. Pisa: Clinical & Exper Rheumatology, v. 32, n. 2, p. 291-296, 2014.
dc.description.abstractObjectives: Steroid joint injection is indicated as starting treatment for juvenile idiopathic arthritis, but its effect as single treatment has not been explored. Our aim was to estimate arthritis remission probability after single or repeated injections.MethodsConduct a retrospective analysis of inactive arthritis status, remission on medication and remission off medication, estimating cumulative probability and mean time to survival, from the first joint injection session to the last follow-up visit or disease-modifying anti-rheumatic drugs initiation. Remission and time to achieve remission status after single or repeated injections were compared.ResultsSeventy-seven patients with 4-year medium follow-up and 254 treated joints, were reviewed. Eighty-three percent of the individuals had oligoarticular subtype and 57% had persistent oligoarticular course. Overall, 26% achieved remission off medication status, 4% remission on medication and 38% initiated disease-modifying anti-rheumatic drugs. Survival analysis resulted in mean time of achieving inactive disease status, remission on medication and off medication of 8, 11 and 56 months, respectively. The cumulative probability of remission off medication was 2% at 12 months, 8% at 24 months and 18% at 36 months. Frequency of inactive disease, remission on medication and remission off medication status decreased proportionally following repeated joint injections in comparison with the frequency of the same status for those receiving single treatment.ConclusionThe dropout rates due to anti-rheumatic drugs initiation indicated limited long-term benefits of intra-articular steroids for juvenile idiopathic arthritis.en
dc.description.sponsorshipUNESP (BAAE III)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.publisherClinical & Exper Rheumatology
dc.relation.ispartofClinical and Experimental Rheumatology
dc.sourceWeb of Science
dc.subjectjuvenile idiopathic arthritisen
dc.subjecttriamcinolone hexacetonideen
dc.titleProbability of remission of juvenile idiopathic arthritis following treatment with steroid joint injectionen
dcterms.rightsHolderClinical & Exper Rheumatology
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.description.affiliationUNESP Sao Paulo, Botucatu Med Sch, Paediat Rheumatol Unit, Sao Paulo, Brazil
dc.description.affiliationUnespUNESP Sao Paulo, Botucatu Med Sch, Paediat Rheumatol Unit, Sao Paulo, Brazil
dc.rights.accessRightsAcesso restrito
dc.description.sponsorshipIdCNPq: 301644/2010-1
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt
Localize o texto completo

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record